Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$147,209
-$618,355 QoQ
Shares Held
585
-83.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3,990
of 4,153 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coppell Advisory Solutions LLC holds $394,497 across 3 Drug Manufacturers - General names. ABBV ranks #2 (37.3% of the industry book) .
All Filings in ABBV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,209 | 585 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $765,564 | 3,520 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $747,847 | 3,273 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $747,411 | 3,228 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $575,236 | 3,099 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $598,389 | 2,856 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $286,452 | 1,612 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $310,438 | 1,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $395,525 | 2,306 | Shares | Sole | 2024-08-15 | |
| 2023-12-31 | $312,729 | 2,018 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $132,663 | 890 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $168,951 | 1,254 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $261,207 | 1,639 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $287,664 | 1,780 | Shares | Sole | 2023-05-19 | |
| No filing history on record for this holder in this stock. | ||||||